| Financial Year |
March 31 2023 |
| Monetary Funds |
2,512,174,521.37 |
| Held-for-trading Financial Assets |
965,612,635.94 |
| Notes Receivable |
-- |
| Accounts Receivable |
294,117,874.18 |
| Advances to Suppliers |
21,866,678.86 |
| Other Receivables |
29,429,961.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,605,703.87 |
| Other Current Assets |
16,530,734.50 |
| Total Current Assets |
3,847,338,110.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
18,186,547.73 |
| Long-term Equity Investment |
1,207,242,233.02 |
| Investment Properties |
181,466,521.41 |
| Fixed Assetes |
629,306,009.44 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
71,410,957.29 |
| R&D expenses |
-- |
| Goodwill |
3,808,266.80 |
| Long-Term Deferred and Prepaid Expenses |
7,600,141.26 |
| Deferred Income Tax Assets |
102,594,341.33 |
| Other Non-Current Assets |
40,950,666.67 |
| Sub-Total of Non-Current Assets |
2,952,571,073.54 |
| Total Assets |
6,799,909,183.78 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
322,862,482.78 |
| Accounts Received In Advance |
553,511.94 |
| Employee Compensation Payable |
397,389,469.73 |
| Taxes Payable |
264,738,470.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
40,377,197.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,555,070.67 |
| Other Current Liabilities |
25,204,569.97 |
| Sub-Total of Current Liabilities |
1,605,140,499.74 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,553,516.91 |
| Other Non-Current Liabilities |
72,297,784.19 |
| Sub-Total of Non-Current Liabilities |
103,349,241.26 |
| Total Liabilities |
1,708,489,741.00 |
| Paid-In Capital(Or Share Stock) |
71,928,782.00 |
| Capital Surplus |
1,357,971,409.06 |
| Surplus Reserve |
35,964,391.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,783,378,763.08 |
| Minority Stockholder's Interest |
804,791,600.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,286,627,842.39 |
| Owner's Equity（Stockholder's Equity） |
5,091,419,442.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,799,909,183.78 |
